DouglasJohnsonMD

Physician

Are you Dr. Johnson?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 11 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Dr. Douglas Johnson, MD is a psychiatrist in Rusk, Texas. He is currently licensed to practice medicine in Texas, Michigan, and Iowa.

USAF School of Aerospace Medicine Aerospace MedicineResidency, Preventive Medicine, 1977 - 1979
University of Iowa Hospitals and ClinicsResidency, Psychiatry, 1963 - 1966
Baylor College of MedicineInternship, Transitional Year, 1962 - 1963
Baylor College of MedicineClass of 1962

PubMed

Bond with Me if You Can! Natural Product, Covalent Ligand, and Reactivity-Based Probe Compete for Cysteine in PP2A Complex
Douglas S. Johnson, Douglas S. Johnson> ;Cell Press. 2017 Nov 18
Infection Prevention and the Medical Director: Uncharted Territory.
Kapoian, T.,Meyer, K. B.,Johnson, D. S.> ;Clin J Am Soc Nephrol. 2015 Feb 25
Discovery of PF-00217830: aryl piperazine napthyridinones as D2 partial agonists for schizophrenia and bipolar disorder.
Johnson, D. S.,Choi, C.,Fay, L. K.,Favor, D. A.,Repine, J. T.,White, A. D.,Akunne, H. C.,Fitzgerald, L.,Nicholls, K.,Snyder, B. J.,Whetzel, S. Z.,Zhang, L.,Serpa, K. A.> ;Bioorg. Med. Chem. Lett.. 2011 Mar 01
Strategies for discovering and derisking covalent, irreversible enzyme inhibitors.
Johnson, D. S.,Weerapana, E.,Cravatt, B. F.> ;Future Med Chem. 2010 Jul 20
Benzothiophene piperazine and piperidine urea inhibitors of fatty acid amide hydrolase (FAAH).
Johnson, D. S.,Ahn, K.,Kesten, S.,Lazerwith, S. E.,Song, Y.,Morris, M.,Fay, L.,Gregory, T.,Stiff, C.,Dunbar, J. B.,Liimatta, M.,Beidler, D.,Smith, S.,Nomanbhoy, T. K.,...> ;Bioorg. Med. Chem. Lett.. 2009 Apr 24
Join now to see all